Correlation Between Crinetics Pharmaceuticals and Alx Oncology
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Alx Oncology Holdings, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Alx Oncology.
Diversification Opportunities for Crinetics Pharmaceuticals and Alx Oncology
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Crinetics and Alx is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Alx Oncology go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Alx Oncology
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.67 times more return on investment than Alx Oncology. However, Crinetics Pharmaceuticals is 1.49 times less risky than Alx Oncology. It trades about 0.07 of its potential returns per unit of risk. Alx Oncology Holdings is currently generating about -0.04 per unit of risk. If you would invest 1,832 in Crinetics Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 3,774 from holding Crinetics Pharmaceuticals or generate 206.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Alx Oncology Holdings
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Alx Oncology Holdings |
Crinetics Pharmaceuticals and Alx Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Alx Oncology
The main advantage of trading using opposite Crinetics Pharmaceuticals and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| Alx Oncology vs. Cabaletta Bio | Alx Oncology vs. Viracta Therapeutics | Alx Oncology vs. Eyepoint Pharmaceuticals | Alx Oncology vs. Biomea Fusion |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |